Exapto was founded by Guillaume Dupont, Philippe Marlière, Xavier Manière in 2024.

Who are Exapto's investors?

Exapto's investors include Satgana.

Where is Exapto headquartered?

Exapto is headquartered in Paris, FR.

Exapto

Paris, FR · Founded 2024 · 4 employees on LinkedIn · 1 known investors

Find your way into Exapto

620 people in our graph share verified history with the Exapto team — schools, employers, funds. One of them is your warm intro.

Paul Kwanunlockedknows Guillaume Dupont · together at Stanford University (overlapped)

×10knows the team · via Stanford University

knows the team · via France Digitale

Exapto develops engineered biocomponents — novel patented metabolic pathways and enzymes — for industrial biomanufacturing, aimed at improving existing bioproductions and enabling access to chemicals that were previously unreachable from renewable resources. The company combines synthetic biology and AI in its R&D stack to produce key chemicals for the biomanufacturing industry.

AI & Machine Learning Biotech Deep Tech

Founders & leadership

Exapto was founded in 2024 by Guillaume Dupont, Philippe Marlière, and Xavier Manière.

Guillaume Dupont inCEO & Co-FounderGuillaume Dupont is CEO and co-founder of Exapto, which develops engineered biocomponents and metabolic pathways for industrial biomanufacturing. He previously worked on investments within the CapHorn fund at the Anaxago group.

Philippe MarlièreScientific Co-Founder

Xavier Manière inCTO & Co-FounderXavier Manière is CTO and co-founder of Exapto, which develops engineered biocomponents—patented metabolic pathways and enzymes—for industrial biomanufacturing using synthetic biology and AI. He has over 14 years of experience in the pharmaceutical and biotechnology sectors, with expertise in strategy and project team leadership.

Investors · 1

SatganaLuxembourg · $110K – $550K

Frequently asked questions

What does Exapto do?: Exapto develops engineered biocomponents — novel patented metabolic pathways and enzymes — for industrial biomanufacturing, aimed at improving existing bioproductions and enabling access to chemicals that were previously unreachable from renewable resources. The company combines synthetic biology and AI in its R&D stack to produce key chemicals for the biomanufacturing industry.
Who founded Exapto?: Exapto was founded by Guillaume Dupont, Philippe Marlière, Xavier Manière in 2024.
Who are Exapto's investors?: Exapto's investors include Satgana.
Where is Exapto headquartered?: Exapto is headquartered in Paris, FR.